Yves-Loic Martin

Collaborative Investment in Biotech, Greentech & Deeptech Startups from a group of early-stage start-up business angels (BAs) Three experienced BAs at the heart of this human-scale group : Anaïs Beynel - former lawyer, BA and LP in impact and health John Samson - web entrepreneur turned BA in Bordeaux Yves-Loïc Martin - co-founder of Eurofins - including other occasional BAs (data and AI experts, specialist doctors, financiers...) - connected with several co-investors, including specialized funds. - supported by freelance experts in recruitment, B2B marketing, internationalization... Pooled investment tickets from €100K to €500K Thesis: early-stage impact/greentech/deeptech/biotech start-ups First round of funding only, ambitious start-ups without revenue or market validation welcome. Contact: reach@ajyl.eu We strive to respond to all financing requests that align with our investment thesis within 15 days. We may not respond to projects that fall outside our thesis. Biotech / Health - TREEFROG THERAPEUTICS, biotech enabling the development of cell therapies for all - OCEAN DX, fast and accurate Sepsis diagnostics saving lives - BYORNA, bioproduction technology to mass produce mRNA ... Greentech - BIOHAP, water treatment of metal pollutants - AURA AERO, aircrafts that accelerate air transport decarbonization - TOOPI ORGANICS, agritech turning human urine into fertilizers - LEAKMITED, AI-Powered water leaks detection - CODABENE, foodtech reducing waste in supermarkets, acquired by TOO GOOD TO GO ... Energy / Hard Tech - KEYSOM, processor architecture software for semiconductors - NRGYBOX, IoT & software reducing street lighting energy consumption - AIR BOOSTER, turning steel cladding into solar energy power ... SaaS - KESTRA, open source declarative data orchestration - ALTER-ID, data anonymization SaaS - QATENT, patent drafting software - acquired by QUESTEL ...

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Collaborative Investment in Biotech, Greentech & Deeptech Startups from a group of early-stage start-up business angels (BAs) Three experienced BAs at the heart of this human-scale group : Anaïs Beynel - former lawyer, BA and LP in impact and health John Samson - web entrepreneur turned BA in Bordeaux Yves-Loïc Martin - co-founder of Eurofins - including other occasional BAs (data and AI experts, specialist doctors, financiers...) - connected with several co-investors, including specialized funds. - supported by freelance experts in recruitment, B2B marketing, internationalization... Pooled investment tickets from €100K to €500K Thesis: early-stage impact/greentech/deeptech/biotech start-ups First round of funding only, ambitious start-ups without revenue or market validation welcome. Contact: reach@ajyl.eu We strive to respond to all financing requests that align with our investment thesis within 15 days. We may not respond to projects that fall outside our thesis. Biotech / Health - TREEFROG THERAPEUTICS, biotech enabling the development of cell therapies for all - OCEAN DX, fast and accurate Sepsis diagnostics saving lives - BYORNA, bioproduction technology to mass produce mRNA ... Greentech - BIOHAP, water treatment of metal pollutants - AURA AERO, aircrafts that accelerate air transport decarbonization - TOOPI ORGANICS, agritech turning human urine into fertilizers - LEAKMITED, AI-Powered water leaks detection - CODABENE, foodtech reducing waste in supermarkets, acquired by TOO GOOD TO GO ... Energy / Hard Tech - KEYSOM, processor architecture software for semiconductors - NRGYBOX, IoT & software reducing street lighting energy consumption - AIR BOOSTER, turning steel cladding into solar energy power ... SaaS - KESTRA, open source declarative data orchestration - ALTER-ID, data anonymization SaaS - QATENT, patent drafting software - acquired by QUESTEL ...

Alternative Assets Finance invests in European technology companies lead by visionary entrepreneurs determined to seize emerging opportunities in times of accelerated changes. We aim to finance impact driven start-ups, ideally built upon disruptive deep technologies or dynamic Open-Source communities.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.